BioCapital 2015

Regenesance presenting on BioCapital Europe. March 26, 2015.


EPIC Biotech, October 2015

Regenesance presenting on EPIC Biotech. October 8, 2015.


Spring 2014

Stichting ALS Nederland to invest in Regenesance and become a shareholder.


June 2014

Regenesance antibody fully characterized and ready for production.


May 2014

Regenesance CSO Frank Baas to present at the 3rd meeting of the Belgian-Dutch Neuromuscular Study Club.


April 2014

Regenesance leading scientist Dr. Valeria Ramaglia to give a presentation at the Annual Traumatic Brain Injury Conference in Washington.


Winter 2013

Regenesance Patent estate granted further allowence in different countries.